Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy

BACKGROUND: People who inject drugs (PWID) constitute 60% of the approximately 5 million people in the U.S. infected with hepatitis C virus (HCV). Treatment of PWID is complex due to addiction, mental illness, poverty, homelessness, lack of positive social support, poor adherence-related skills, low...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Infect Dis
Glavni autori: Akiyama, Matthew J., Agyemang, Linda, Arnsten, Julia H., Heo, Moonseong, Norton, Brianna L., Schackman, Bruce R., Linas, Benjamin P., Litwin, Alain H.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5807730/
https://ncbi.nlm.nih.gov/pubmed/29426304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-018-2964-5
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items